CVS Health CDR (CVS.CA) Stock Fundamental Analysis

TSX:CVS

19.25 CAD
+0.39 (+2.07%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, CVS scores 4 out of 10 in our fundamental rating. CVS was compared to 13 industry peers in the Health Care Providers & Services industry. While CVS is still in line with the averages on profitability rating, there are concerns on its financial health. CVS is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CVS was profitable.
  • CVS had a positive operating cash flow in the past year.
  • Of the past 5 years CVS 4 years were profitable.
  • CVS had a positive operating cash flow in 4 of the past 5 years.
CVS.CA Yearly Net Income VS EBIT VS OCF VS FCFCVS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • CVS has a better Return On Assets (0.18%) than 61.54% of its industry peers.
  • CVS has a Return On Equity of 0.64%. This is in the better half of the industry: CVS outperforms 61.54% of its industry peers.
  • The Return On Invested Capital of CVS (4.90%) is better than 76.92% of its industry peers.
  • CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 7.74%.
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROIC 4.9%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
CVS.CA Yearly ROA, ROE, ROICCVS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • CVS has a Profit Margin of 0.12%. This is in the better half of the industry: CVS outperforms 61.54% of its industry peers.
  • In the last couple of years the Profit Margin of CVS has declined.
  • Looking at the Operating Margin, with a value of 2.73%, CVS is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CVS has declined.
  • The Gross Margin of CVS (13.88%) is worse than 84.62% of its industry peers.
  • In the last couple of years the Gross Margin of CVS has declined.
Industry RankSector Rank
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
CVS.CA Yearly Profit, Operating, Gross MarginsCVS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CVS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CVS.CA Yearly Shares OutstandingCVS.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CVS.CA Yearly Total Debt VS Total AssetsCVS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

  • An Altman-Z score of 1.99 indicates that CVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CVS's Altman-Z score of 1.99 is fine compared to the rest of the industry. CVS outperforms 76.92% of its industry peers.
  • The Debt to FCF ratio of CVS is 10.46, which is on the high side as it means it would take CVS, 10.46 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.46, CVS is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • CVS has a Debt/Equity ratio of 0.85. This is a neutral value indicating CVS is somewhat dependend on debt financing.
  • CVS's Debt to Equity ratio of 0.85 is fine compared to the rest of the industry. CVS outperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Altman-Z 1.99
ROIC/WACC0.72
WACC6.77%
CVS.CA Yearly LT Debt VS Equity VS FCFCVS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • CVS has a Current Ratio of 0.83. This is a bad value and indicates that CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CVS has a Current ratio of 0.83. This is in the better half of the industry: CVS outperforms 61.54% of its industry peers.
  • A Quick Ratio of 0.63 indicates that CVS may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.63, CVS perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.63
CVS.CA Yearly Current Assets VS Current LiabilitesCVS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.54% over the past year.
  • Measured over the past years, CVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.11% on average per year.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.17%

3.2 Future

  • Based on estimates for the next years, CVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.08% on average per year.
  • The Revenue is expected to grow by 4.26% on average over the next years.
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue Next Year2.59%
Revenue Next 2Y3.98%
Revenue Next 3Y5.31%
Revenue Next 5Y4.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CVS.CA Yearly Revenue VS EstimatesCVS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
CVS.CA Yearly EPS VS EstimatesCVS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.09, the valuation of CVS can be described as very cheap.
  • Based on the Price/Earnings ratio, CVS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, CVS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 1.94, the valuation of CVS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CVS is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. CVS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.09
Fwd PE 1.94
CVS.CA Price Earnings VS Forward Price EarningsCVS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 92.31% of the companies in the same industry are more expensive than CVS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.84
EV/EBITDA N/A
CVS.CA Per share dataCVS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300 400

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y10.96%
EPS Next 3Y11.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.41%, CVS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.40, CVS pays a better dividend. On top of this CVS pays more dividend than 84.62% of the companies listed in the same industry.
  • CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

  • The dividend of CVS has a limited annual growth rate of 5.72%.
  • CVS is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 722.81% of the earnings are spent on dividend by CVS. This is not a sustainable payout ratio.
  • The dividend of CVS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP722.81%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
CVS.CA Yearly Income VS Free CF VS DividendCVS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B
CVS.CA Dividend Payout.CVS.CA Dividend Payout, showing the Payout Ratio.CVS.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CVS Health CDR

TSX:CVS (2/27/2026, 7:00:00 PM)

19.25

+0.39 (+2.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners89.6%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap24.44B
Revenue(TTM)N/A
Net Income(TTM)469.00M
Analysts80
Price Target23.15 (20.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend3.61
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)-0.28%
PT rev (3m)N/A
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.04%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.09
Fwd PE 1.94
P/S 0.05
P/FCF 2.84
P/OCF 1.96
P/B 0.25
P/tB N/A
EV/EBITDA N/A
EPS(TTM)9.23
EY47.95%
EPS(NY)9.9
Fwd EY51.44%
FCF(TTM)6.78
FCFY35.22%
OCF(TTM)9.81
OCFY50.97%
SpS424.51
BVpS78.56
TBVpS-41.51
PEG (NY)0.29
PEG (5Y)N/A
Graham Number127.73
Profitability
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROCE 6.61%
ROIC 4.9%
ROICexc 5.26%
ROICexgc 19.51%
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
FCFM 1.6%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.71%
Interest Coverage -3.53
Cash Conversion N/A
Profit Quality 1341.79%
Current Ratio 0.83
Quick Ratio 0.63
Altman-Z 1.99
F-Score6
WACC6.77%
ROIC/WACC0.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.17%
Revenue Next Year2.59%
Revenue Next 2Y3.98%
Revenue Next 3Y5.31%
Revenue Next 5Y4.26%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.78%
EBIT Next 3Y19.74%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%

CVS Health CDR / CVS.CA FAQ

What is the fundamental rating for CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to CVS.CA.


What is the valuation status of CVS Health CDR (CVS.CA) stock?

ChartMill assigns a valuation rating of 8 / 10 to CVS Health CDR (CVS.CA). This can be considered as Undervalued.


What is the profitability of CVS stock?

CVS Health CDR (CVS.CA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CVS stock?

The Earnings per Share (EPS) of CVS Health CDR (CVS.CA) is expected to grow by 7.28% in the next year.


Can you provide the dividend sustainability for CVS stock?

The dividend rating of CVS Health CDR (CVS.CA) is 4 / 10 and the dividend payout ratio is 722.81%.